Cargando…
Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers
Background: Ulcerative colitis (UC) is a chronic relapsing disease, which needs a continue monitoring, especially during biological therapies. An increasing number of patients is treated with anti-Tumor Necrosis factor (TNF) drugs, and current research is focalized to identify biomarkers able to mon...
Autores principales: | Capecchi, Riccardo, Migliorini, Paola, Zanzi, Federico, Maltinti, Simona, Puxeddu, Ilaria, de Bortoli, Nicola, Bellini, Massimo, Costa, Francesco, Marchi, Santino, Bertani, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062917/ https://www.ncbi.nlm.nih.gov/pubmed/33897440 http://dx.doi.org/10.3389/fphar.2021.654319 |
Ejemplares similares
-
Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis
por: Bertani, Lorenzo, et al.
Publicado: (2021) -
CXCL12/SDF-1 in IgG4-Related Disease
por: Capecchi, Riccardo, et al.
Publicado: (2021) -
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study
por: Bertani, Lorenzo, et al.
Publicado: (2020) -
Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review
por: Puxeddu, Ilaria, et al.
Publicado: (2018) -
New biomarkers in SLE: from bench to bedside
por: Capecchi, Riccardo, et al.
Publicado: (2020)